BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8260736)

  • 1. Clinical use of antacids.
    Halter F
    J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):61-74. PubMed ID: 8260736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
    Koelz HR
    Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of antacids in ulcer therapy. Continuing the tradition or scientific progress?].
    Szelenyi I
    Leber Magen Darm; 1987 Jul; 17(3):150-62. PubMed ID: 3613813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [25 years of gastric acid blockers].
    Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of 3rd-generation antacid preparations for the treatment of patients with nonulcerous dyspepsia and peptic ulcer complicated by reflux esophagitis].
    Degtiareva II; Bogdanov A; Khatib Z; Kharchenko NV; Lodianaia EV; Palladina OL; Opanasiuk ND
    Lik Sprava; 1994; (5-6):119-22. PubMed ID: 7831874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of Helicobacter pylori eradication on chronic use of acid-suppressant medication by patients in general practice; a randomised, double-blind study].
    Hurenkamp GJ; Grundmeijer HG; van der Ende A; Tytgat GN; Assendelft WJ; van der Hulst RW
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2390-6. PubMed ID: 15615275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in treatment no. 7. Gastric and duodenal ulceration and dyspepsia.
    Matts SG
    Br J Clin Pract; 1972 Oct; 26(10):467-8. PubMed ID: 5083426
    [No Abstract]   [Full Text] [Related]  

  • 11. Why do apparently healthy people use antacid tablets?
    Graham DY; Smith JL; Patterson DJ
    Am J Gastroenterol; 1983 May; 78(5):257-60. PubMed ID: 6846300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guideline "Dyspepsia"].
    de Wit NJ; van Barneveld TA; Festen HP; Loffeld RJ; van Pinxteren B; Numans ME;
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1386-92. PubMed ID: 15997691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antacids. Indications and limitations.
    Ching CK; Lam SK
    Drugs; 1994 Feb; 47(2):305-17. PubMed ID: 7512903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical therapy of gastroesophageal reflux disease in secondary and tertiary care settings.
    Tytgat GN
    Yale J Biol Med; 1999; 72(2-3):219-26. PubMed ID: 10780584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Internal medicine therapy in reflux disease].
    Flad J
    Praxis (Bern 1994); 1996 Nov; 85(45):1432-8. PubMed ID: 8975352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
    Laine L
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of dyspepsia.
    Shearman DJ
    Aust Fam Physician; 1977 Aug; 6(8):1028-32. PubMed ID: 921613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
    Geus WP
    Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication treatment for Helicobacter pylori in general practice.
    Fraser AG; Moore L; Berry S; Arroll B
    N Z Med J; 1996 Nov; 109(1033):422-4. PubMed ID: 8941293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.